Introduction remainder of the attacked molecule then possesses an unpaired electron and has therefore become a free radical Atherosclerosis and its complications, most notably coronary heart disease (CHD), continue to be the major cause of (Figure 1 ). Subsequent events depend on the reactivity of the target radical. If high, further target molecules will be premature death in the developed world. A variety of important risk factors for its development including hyperattacked and lead to propagation of a free radical chain reaction. In this way the presence of a single radical may cholesterolaemia, hypertension, smoking and diabetes have been identified. Although the outstanding pathological initiate a sequence of electron transfer (redox) reactions. In the case of antioxidant targets the resultant radical has low feature of atherosclerosis is the collection of cholesterol esters from circulating lipoproteins in the intimal layer of reactivity and the chain is broken. Most of the important free radicals in human biology are large arteries the concentration of cholesterol in circulating plasma alone remains a relatively poor predictor of disease.
derived from oxygen. The tetravalent reduction of oxygen in the mitochondrial electron transport is necessary to This has therefore stimulated research into the pathophysiological mechanisms underlying the development of atherogenerate energy. However, the reduction is not 100% efficient and some partially reduced oxygen may leak from sclerosis and, in particular, into the factors that facilitate the deposition of lipoproteins in the vascular wall. The first part the system in the form of the superoxide radical (O 2 V − ).
Superoxide radicals may dismute (either spontaneously or, of this article will review the accumulating evidence that free radical-induced oxidation of lipoproteins may be an more rapidly, catalysed by superoxide dismutase) to form hydrogen peroxide (H 2 O 2 ). Neither species is a particularly important event in this process. By extension, the second part will review the evidence that dietary antioxidants which powerful oxidant but both may interact with transition metal ions such as Fe 2+ and Cu + to generate the highly retard oxidation may slow or prevent the development of atherosclerosis and CHD in vivo.
reactive hydroxyl radical (OHV ). The latter is probably responsible for much of the biological damage in vivo. Other sources of free radicals include the respiratory burst of Free radicals: definition and sources leukocytes, reperfusion of previously hypoxic tissues, autoxidation of molecules such as glucose and exogenous sources A free radical can be defined as 'any species capable of independent existence that contains one or more unpaired such as cigarette smoke. electrons' occupying an atomic orbital by itself. This situation is energetically unstable, often making such species
Free radical-induced damage: lipid peroxidation highly reactive and short-lived. Stability is achieved by the removal of electrons from (i.e. oxidation of ) surrounding Free radicals can disturb biological systems by damaging a variety of their constituent molecules. Lipids, proteins, carbohydrates and DNA are all potential targets for the Figure 1 The reaction of a free radical with a non-radical species. The unpaired electron of the free radical is highly reactive and tends to abstract an electron from an electron pair of the non-radical target. Following electron transfer the free radical is now stable but a target radical has been created. Subsequent events depend on the reactivity of the target radical. If high further target molecules will be attacked and lead to propagation of a free radical chain reaction. In the case of antioxidant targets the resultant radical Target  Free radical   electron   transfer   unpaired  electron   oxidized  reduced has low reactivity and the chain is broken.
Polyunsaturated fatty acid residues (that is, fatty acids with covalent bond is weaker. Hydroxyl radicals are certainly capable of this but superoxide is apparently not and would more than one carbon-carbon double bond) in lipoproteins have a chemical structure that makes them a particularly also be unlikely to enter the hydrophobic membrane interior. In many systems the presence of metal ions such as vulnerable target for free radical oxidation (lipid peroxidation) which may be of greatest relevance to atherogenesis. iron seems to be essential for initiation presumably because it functions as a template for local hydroxyl formation. Lipid peroxidation is initiated if a radical enters the lipid phase and has sufficient reactivity to abstract a hydrogen Removal of a hydrogen atom produces a carbon centred radical which stabilizes by a molecular rearrangement to atom from a fatty acid bis-allylic methylene (-CH 2− ) group (Figure 2 ). This process is favoured in carbon-hydrogen form a conjugated diene which shows characteristic u.v. absorption at 234nm [1] . If oxygen is available (it is several bonds adjacent to unsaturated double bonds since the times more soluble in lipid than aqueous phases) the likely fate of this radical is to combine to produce a peroxyl radical. Once formed a peroxyl radical has sufficient reactivity to abstract a hydrogen atom from an adjacent unsaturated fatty acid to produce a further carbon-centred radical that itself reacts with oxygen to form a peroxyl radical. This is the propagation stage of lipid peroxidation. Therefore, if it is unchecked a single radical initiation can lead to long chains of lipid hydroperoxide ( peroxide) formation. Lipid hydroperoxides are unstable and tend to decompose rapidly to form secondary products. These include alkanes like ethane and pentane detectable by gas chromatography and aldehydes such as malondialdehyde and 4-hydroxy-2,3-trans-nonenal. These products are themselves toxic and may be responsible for many of the deleterious effects of lipid peroxidation. In particular, aldehydes may interact with the apolipoprotein moiety of lipoproteins and prevent normal cellular recognition [2] . from the aforementioned sources [3] [4] [5] (Table 1 ). An peroxidation. Oxidizing species such as hydroxyl, peroxyl and antioxidant can be considered as a molecule that, when alkoxyl radicals and singlet oxygen are capable of abstracting one of the bisallylic hydrogen atoms on the carbon atom between present at low concentrations compared with those of an two double bonds of an unsaturated fatty acid. The radical oxidizable substrate, significantly inhibits oxidation of that product undergoes molecular rearrangement to a conjugated substrate. This antioxidant effect can be achieved in three diene which reacts rapidly with oxygen to form a peroxy radical. different ways, as illustrated in Figure 3 . Thus the intracellular The latter can itself abstract a hydrogen atom from unsaturated environment contains enzymes such as superoxide dismutase, fatty acids leading to propagation of the reaction and production catalase and glutathione peroxidase that catalyse the breakof a lipid peroxide. Lipid peroxides are relatively unstable and down of oxidants generated in situ by cellular metabolism. min and albumin. In spite of these mechanisms free radicals are constantly generated in vivo. For this reason body fluids contain a rich array of low molecular weight molecules that preferentially react with (scavenge) free radicals before more important structures are damaged but are sacrificed (consumed) in the process. These can be conveniently divided into those that are water-soluble and those that are lipid-soluble and exist
Antioxidant defences

Target
Free radical is not a particularly active radical scavenger other than at low oxygen tensions; the precise pathophysiology of its include bilirubin and thiol groups, which are mostly associated with albumin.
antioxidant function however remains to be defined. Vitamin E is a lipid-soluble antioxidant and refers to alpha-tocopherol and other related tocotrienols. Important
Oxidative-modification hypothesis of atherosclerosis dietary sources are vegetable oils, cereal grains, egg yolk, liver and milk. It is the major antioxidant of lipoproteins Basic research has now advanced our understanding of some of the biochemical events that lead to the development of and membranes where it acts as a powerful chain-breaking antioxidant. The efficient function of vitamin E in vivo the atherosclerotic plaque [7] . Most of the cholesterol in the mature lesion originates from circulating low-density depends upon its regeneration following oxidation to the tocopheryl radical. This is achieved by a direct electron lipoprotein (LDL) particles which have been ingested by subendothelial macrophages. However, when exposed to transfer with vitamin C at the lipid-water interface of lipoproteins (and membranes) [6] . Ubiquinol-10 (reduced high concentrations of native LDL macrophages in culture do not accumulate cholesterol due to down-regulation of co-enzyme Q 10 ) is present in much lower concentration than vitamin E but is also an efficient free radical scavenger LDL receptor-mediated uptake in the cholesterol-replete state [8] . In contrast, oxidatively modified forms of LDL are and may also contribute to the regeneration of tocopherol. Finally, beta-carotene is the most abundant carotenoid and much more avidly taken up by cultured macrophages which become converted to cholesterol-laden 'foam cells', a [13] . However, LDL can be oxidized by all of the major cell types found in the arterial wall and also by exposure to characteristic histological feature of the atherosclerotic lesion. The rapid uptake of the oxidatively modified LDL has been transition metal ions such as copper in vitro. Furthermore, the oxidation of LDL is facilitated by binding to local attributed to a new receptor known as the 'scavenger receptor' which is not down-regulated by cholesterol intimal proteoglycans [14] . Oxidized LDL may also be atherogenic by mechanisms accumulation [9] (Figure 4 ). Recognition of LDL by the scavenger receptor depends on derivatization of lysine other than its rapid uptake into macrophages via the scavenger receptor. Oxidized forms of LDL are a chemoatresidues of apolipoprotein B by aldehydes produced by the spontaneous decomposition of lipid hydroperoxides [2] .
tractant for macrophages and smooth muscle cells [15] and facilitate monocyte adhesion to endothelium and entry into Although oxidation of LDL is not likely in the circulation, all of the cells of the vessel wall-endothelial cells, smooth the subendothelial space [16] . They are also cytotoxic towards arterial endothelial cells [17] and inhibit the release muscle cells and macrophages-can modify LDL in vitro [10] [11] [12] . The mechanisms by which LDL particles become of nitric oxide and the resulting endothelium-dependent vasodilatation [18] . oxidized are, as yet, incompletely understood but are likely to involve exposure to free radicals in the intimal layer of
The presence of oxidized LDL in vivo has been wellestablished. Oxidatively modified forms of LDL have been the vascular wall, possibly generated by transition metal ions identified in human atherosclerotic plaques by extraction [19] or immunochemical detection [20] and circulating antibodies that recognize epitopes on oxidized LDL can be found in vivo [21] . The titres of LDL auto-antibodies have also been correlated with the progression of atherosclerosis. With these discoveries the oxidative-modification hypothesis of atherosclerosis was established and further research directed towards the factors that influence the susceptibility of the human LDL particle to oxidation ( Table 2) . One of the most important factors appears to be lipidsoluble antioxidant vitamin content, particularly vitamin E (alpha-and gamma-tocopherol), ubiquinol-10 and betacarotene in order of abundance [12] . These antioxidant vitamins exist in the hydrophobic environment of the lipoprotein particle where they protect vulnerable polyunsat- urated fatty acids from free radical oxidation ( Figure 5 ). In Figure 5 The structure of the LDL particle. The particle has two this way they prevent the production of the toxic products vitamin E in vitro [1, 24] or in vivo [25] is much harder to 510 000) which accounts for most of the protein content and is oxidize in vitro. In addition, several other factors also influence the particle m.wt.=2 500 000, density range 1.019-1.063 g ml that particles of varying fatty acid content show different behaviour in such circumstances. For example, LDL enriched in linoleic acid was more susceptible to oxidation while that Evidence for a protective role of antioxidants in vivo enriched in monounsaturated fatty acids was more resistant
Evidence comes from studies of antioxidant intervention in [26, 27] . Small dense LDL particles are also more easy to animals and epidemiological observations in man (Table 3) . oxidize than more buoyant particles [28] . This may explain the apparent risk for CHD conferred by the presence of an excess of these particles. Finally, the binding of LDL particles
Animal studies to proteoglycans, glycation and the presence of preformed The potential beneficial role for both natural and synthetic lipid peroxides (which greatly facilitate subsequent metalantioxidants in the prevention of atherosclerosis has been induced oxidation) are also important.
investigated in a variety of animal models [29] . Trials of [42] found an inverse association majority of investigators have seen benefits [30] [31] [32] , some have found the vitamin either ineffective or deleterious [33] .
between cholesterol-adjusted vitamin E and cardiovascular mortality in four European populations (Southwest Finland, Plasma cholesterol levels in these studies were extremely high (15-30 mmol l −1 ) and vitamin E supplements in some North Karelia, Scotland and Italy) although this failed to achieve statistical significance. studies very high (1000-10,000 mg kg −1 ).
By contrast, investigations of the impact of vitamin C on Such comparative studies are limited by potential confounding factors. Much of the dietary evidence relates to atherogenesis have suggested in the main that vitamin C deficient diets are associated with increased aortic accumuthe intake of fresh fruit and vegetables which may contain non-antioxidant elements that protect against CHD. lation of cholesterol [34] . Although this effect may be due to deficient antioxidant defences, vitamin C deficiency may Similarly, such diets are usually lower in saturated fats and are consumed by individuals displaying other beneficial also have an adverse effect on lipid metabolism and synthesis of structural components in the arterial wall [29] .
including lifestyle characteristics e.g. regular exercise, nonsmoking. Furthermore, they do not take into account likely Most trials of the antioxidant drug probucol have suggested that the development of atherosclerosis is inhibited genetic variability. [35] . Although this effect has been attributed to a decrease in susceptibility of LDL to oxidation [36] , probucol may Intra-population epidemiology Prospective cohort studies within populations identify antioxidant status (dietary intake alter a variety of other physiological processes involved in atherosclerosis, for example, lipid levels. Butylated hydroxyor plasma levels) at the beginning of the study and monitor the cohort for subsequent events. This methodology reduces toluene also inhibits the susceptibility of LDL to oxidation in vitro and retards the progression of atherosclerosis in the possible impact of recall or selection bias found in casecontrol studies (see below) and also removes the possible animal models [37] .
The interpretation of the studies is further complicated influence of CHD on antioxidant levels. Two large studies published in 1993 examined the by the fact that vitamin E and probucol may have other physiological effects. None of the animal studies have relationship between dietary intake of antioxidant vitamins and coronary heart disease. Stampfer et al. [43] followed a demonstrated unequivocally that the above substances are acting entirely by an 'pure' antioxidant mechanism. cohort of 87 245 nurses who were free of coronary disease at entry to the study; during a follow-up period of 8 years However, the generally promising results of small trials with antioxidants in animal models of atherosclerosis has stimu-552 coronary events were identified in the cohort. In comparison with the lowest quintile of vitamin E intake, lated a search for epidemiological evidence that antioxidant intake might influence the rate of atherosclerotic complithe top quintile had a relative risk (RR) of 0.66 (95% CI, 0.50-0.87) after adjustment for age and smoking. Most of cations in human populations.
the risk reduction could be attributed to the use of vitamin E supplements (>100IU day −1 ) with no relationship
Epidemiological studies existing when dietary intake alone was considered. Adjustment for the intake of the other antioxidant vitamins Inter-population epidemiology A number of investigators have attempted to correlate rates of CHD in different populations beta-carotene and ascorbate (which was higher in the supplement using subjects) reduced the apparent impact of with their dietary intake of antioxidants (mostly in fruits and vegetables) or blood antioxidant levels. For example, vitamin E (RR, 0.69; confidence interval, 0.49-0.97). However, at least 2 years of supplement usage was required Armstrong et al. [38] reported a strong inverse association of regional consumption of fresh fruit and vegetables and to have any benefit suggesting that its effect was due to an impact on a chronic disease process such as atherosclerosis. CHD in nine UK regions, with correlation coefficients of r=−0.83 for men (P<0.05) and r=−0.91 for women
The relative risk between highest and lowest quintile of beta-carotene was 0.78 (95% CI 0.59-1.03) with a significant (P<0.05). By contrast, other authors have also tried to link the temporal variation of cardiovascular disease with antioxitrend across quintiles (P=0.02), but Vitamin C intake had no apparent protective effect. However, the vitamin users dant intake. A notable example is the decline in CHD rates in the United States in the 1960s and 1970s which has been as a group in this study were more health conscious with a lower body mass index, a lower intake of saturated fats and ascribed to the concomitant increases in per capita intake of fruits and vegetables [39] or the production of vitamin C a higher intake of fibre. They also smoked less, had more users of hormone replacement therapy and took more supplements [40] .
An alternative approach is to measure plasma levels of vigorous exercise. These factors were adjusted for but other associated but unmeasured confounding factors might have various antioxidants. For example, the World Health Organisation MONICA project compared the risk of had an important influence. Rimm et al.
[44] conducted a similar study amongst ischaemic heart disease mortality with mean plasma antioxidant levels in random samples of 100 individuals from 39 910 male health professionals aged 40-75 years who were followed up for 4 years after completing baseline question-12 European populations with normal cholesterol levels (5.7-6.2 mmol l −1 ) [41] . Both absolute and lipidnaires. In this group 667 CHD events (myocardial infarction or revascularizations) were identified, and men who took standardized vitamin E concentrations showed a strong inverse correlation with CHD mortality rates (r 2 =0.63, 100IU day −1 or more of vitamin E supplements had a relative risk of 0.63 (95% CI, 0.47-0.84) compared with of CHD in this study. Similarly, the Lipid Research Clinic Coronary Primary Prevention Trial measured plasma carotthose who took no supplements. Although the dietary vitamin E intake showed a weak non-significant association enoid content at baseline [52] , and after 14 years of followup, carotenoid levels were inversely related to risk of with the risk of CHD (P=0.11), dietary beta-carotene intake was associated with a reduced risk of CHD in myocardial infarction after adjustment for age, smoking and cholesterol levels. smokers (relative risk, 0.30; 95% CI, 0.11-0.82) and ex-smokers (relative risk, 0.60; 95% CI, 0.38-0.94).
In summary, data from prospective cohort studies suggest that higher dietary intake of vitamin E (primarily from Enstrom et al. [45] studied the vitamin C intake of 11 349 men and women in the United States by dietary recall supplements) is associated with a significant reduction in risk of CHD. Both dietary and plasma measurement studies questionnaire. They found that the cardiovascular mortality rate in the highest third of vitamin C intake was significantly suggest a protective effect of beta-carotene especially among smokers. The data for vitamin C are less convincing. The lower than the lowest (r 2 =0.66; 95% CI=0.53-0.82). This study was limited by the limitations associated with the use role of dietary flavonoids is still under evaluation. Whilst epidemiological studies do suggest some role for of a dietary recall technique and lack of information about vitamin supplements other than vitamin C which may have antioxidants in CHD prevention, spurious associations, rather than cause and effect, cannot be excluded [53] , confounded the result. By contrast, an earlier 12 year study of 1462 Swedish women found no protective effect for because vitamin supplementation may be linked to a generally healthier lifestyle. These epidemiological studies vitamin C on cardiovascular mortality [46] .
The Massachusetts Elderly Cohort Study examined betaalso suggest that prevention of CHD requires large amounts of some vitamins that are difficult if not impossible to obtain carotene intake by personal interview in 1299 participants who were subsequently followed up for an average of 5 from dietary sources alone. years [47] . Within the study group 151 individuals died from CHD related causes of which 47 were fatal myocardial
Case-control studies infarctions. After controlling for confounding variables the relative risk of cardiovascular death from lowest to highest Case control studies compare antioxidant status or intake in identified cases of CHD and appropriately matched controls. quartiles of beta-carotene intake was 1.00, 0.75, 0.65, 0.57 respectively (P for trend=0.016). The similar figures for
The European Community Multicentre (EURAMIC) Study examined the relationship between adipose tissue fatal myocardial infarction alone were 1.00, 0.77, 0.59 and 0.32 (P for trend=0.02). levels of vitamin E and beta-carotene in 683 people with a first myocardial infarction and in 727 hospital-based control Finally, one cohort study reported that self-administered vitamin E supplements above 100IU day −1 reduced the rate individuals in 12 centres [54] ; the age and centre-adjusted risk of myocardial infarction in the lowest quintile of betaof progression of mild and moderate coronary lesions (<50% stenosis) on serial coronary angiography over a 2 year period carotene compared with the highest was 2.62 (95% CI, 1.79-3.83), but after controlling for body mass index and [48] . This therefore provided some evidence that antioxidant vitamin intake reduced progression of coronary artery smoking the odds ratio was reduced to 1.78 (95% CI, 1.17-2.71) with a significant trend across quintiles ( P for atherosclerosis.
To date few dietary studies have concentrated on the trend=0.001). The increased risk was confined mainly to smokers in whom the adjusted odds ratio was 2.39 (95% potential benefits of dietary flavonoids which, among other properties, are powerful antioxidants and can protect LDL CI, 1.35-4.25). However, a low vitamin E level was not associated with an increased risk of myocardial infarction from oxidation in vitro [49] . The Zutphen Elderly Study recorded the dietary intake of flavonoids in a cohort of 805 but the inverse correlation of beta-carotene was strongest at high vitamin E levels. Vitamin E supplement users were elderly Dutch men [50] , with the major dietary sources of flavonoids being tea, onions and apples; during follow-up excluded from this sample. Riemersma et al. [55] studied 6000 men aged 35-54 years 43 men died from CHD, with the relative risk of CHD death in the highest compared to the lowest tertile of in Edinburgh and identified 110 patients with angina by the WHO Chest Pain questionnaire; their plasma antioxidant flavonoid intake being 0.42 (95% CI 0.20-0.88; P value for trend=0.015). This significant relationship persisted after levels were compared with 394 controls randomly selected from the sample. The unadjusted risk of angina was controlling for the intake of other antioxidants.
Rather than assessing dietary intake, some prospective significantly higher in the lowest quintile compared with the highest for vitamin E (odds ratio 2.51, 95% CI studies measured plasma antioxidant status at baseline. The Basel Prospective Study [51] examined a cohort of 2974 1.24-5.10), vitamin C (odds ratio 2.35, 95% CI 1.16-4.78) and beta-carotene (odds ratio 2.64, CI 1. 32-5.29) . The men in a population with relatively high vitamin E levels (median 35 mmol l −1 ). After a 12 year follow-up there was relationship with vitamin E (but not vitamin C or betacarotene) remained significant after controlling for smoking, a slighly increased risk of death from CHD among those subjects in the lowest quartile of plasma levels of betacholesterol, blood pressure, weight and age (odds ratio 2.98, CI 1.07-6.70). Since smoking reduces vitamin C levels it carotene (RR=1.53; 95% CI 1.07-2.20) or vitamin C (RR=1.25; 95% CI 0.77-2.01) at entry compared with was therefore not surprising that its inclusion in a multivariate analysis might diminish the impact of vitamin C. those in the highest quartile independent of vitamin E and other risk factors; low levels of both vitamin C and betaHowever, leukocyte levels are probably a better indicator of total body vitamin C content than levels in plasma which carotene increased the risk further (RR=1.96; 95% CI 1.10-3.50). However, Vitamin E alone was not a predictor may fluctuate. Ramirez & Flowers [56] therefore measured leukocyte vitamin C levels in a case-controlled study of actively treated group (relative risk=0.49, 95% CI= 0.29-0.88). CHD, and found levels to be significantly lower in cases with angiographically proven CHD when compared with
The ATBC Cancer Prevention Study Group [61] performed a randomized trial of the impact of vitamin E matched controls ( P<0.001).
Whilst such case-control study methods offer useful data (50 mg day −1 ), beta-carotene (20 mg day −1 ) or both in a group of 29 133 Finnish smokers aged 50-69 years who about the impact of antioxidants on CHD incidence they do have significant limitations. Firstly, the results are very were treated for 5 to 8 years with the primary aim of preventing lung cancers. Alpha-tocopherol was associated dependent on the selection of the cases and controls, which are usually small groups that are intended to be an adequate with a 5.8% reductiuon in CHD deaths (658 vs 704) but this was apparently offset by an increase in deaths from representation of larger populations; this generalisability may be far from true. The cases and controls may also differ in cancer and haemorrhagic strokes, such that the overall mortality was actually increased by 2% (P=0.6). In this their recall of important confounding factors such as smoking. Finally, they do not take into account the fact study, the mortality was in fact 8% higher in those given beta-carotene (P=0.02) which was a combination of that the index disease (i.e. CHD) itself may adversely influence antioxidant status.
increased deaths from CHD (11.4%) and cancer. This study therefore suggests that beta-carotene alone is not protective However, some of these objections have been overcome by adopting a nested case-control design. In such studies and that carotene may even represent a marker of diets rich in fruit and vegetables which may contain another protective the blood samples are taken at the beginning of the study and at the end of follow-up antioxidant levels are measured component or be a marker for a healthy lifestyle. However, the vitamin E dose was relatively low, and previous only in the cases and appropriately matched controls. This does has the advantage of allowing large cohorts to be epidemiological studies have suggested that significant benefits required 100IU day −1 [44] , although in the Nurses followed for CHD events but limiting the number of sample measurements required. The major problem however is that Health Study [43] even multivitamin preparations containing Vitamin E 30IU day −1 were beneficial (RR, 0.78; 95% CI, reliable storage of antioxidants, especially vitamin C, is difficult. Using a nested case-controlled study, Kok et al. 0.64-0.96). The Cambridge Heart Antioxidant Study (CHAOS) was [57] followed up individuals for 6-9 years and matched 168 controls against 84 subjects who died from cardiovascular a double-blind, placebo-controlled study with stratified randomization of 2002 patients with angiographically proven disease; those in the lowest tertile of serum vitamin E (frozen at −20°C) had a relative risk of 1.5, with wide CHD to placebo or vitamin E (800IU day −1 for the first 546 patients, 400IU day −1 for the remainder) [62] . After confidence intervals that included zero (95% CI 0.6-3.5). Salonen et al. [58] also found no significant association with a median followup of 510 days, vitamin E treatment significantly reduced the combined primary endpoints of serum vitamin E (frozen at −20°C) in 92 cases and 92 controls selected from a cohort of 12 000. By contrast, Street cardiovascular deaths and non-fatal myocardial infarction (RR 0.53; 95% CI, 0.34-0.83; P=0.005). The risk of et al. [59] found a significant inverse relationship between plasma beta-carotene at baseline and risk of subsequent nonfatal myocardial infarction was particularly reduced (RR, 0.23; 95%CI, 0.11-0.47), with beneficial effects apparent myocardial infarction in 125 cases, 125 community-based and 125 hospital-based controls, using samples that had been after 1 year of treatment. All cause mortality was increased slightly in the group allocated vitamin E. However, this frozen at −70°C for up to 15 years. study was probably underpowered to examine mortality and outcome was not examined in relation to baseline plasma Prospective randomized controlled trials vitamin E concentrations in the placebo group. Another unusual feature in CHAOS was the reduction in vitamin E The foregoing discussion provides powerful (but not conclusive) evidence that antioxidants may have some dosage half-way through the trial; whilst the study was not designed to test a dose-response relationship, the initial beneficial effects in preventing atherosclerosis. However, observational studies are limited by the possibility of dosage was based on epidemiological observations [43, 44] . Based on the current available evidence, the role of vitamin confounding factors, i.e. the dietary intake or blood level of an antioxidant may merely represent a marker for other E supplementation is therefore particularly promising in CHD prevention, although the precise mechanisms of its protective dietary factors of lifelstyle traits. These potential benefits of antioxidants can only be rigorously tested in action remain uncertain and further studies are required to ascertain patient groups for whom the benefits would be prospective intervention studies that randomly allocate at risk populations to antioxidant or placebo treatment.
greatest (Table 4) . Other randomized trials of antioxidant supplements are Preliminary data is available from the Physicians' Health Study, a randomized, placebo-controlled, double-blind, 2×2 currently underway. The Physician's Health Study is testing beta-carotene (50 mg on alternate days) in 20 000 healthy factorial design trial of aspirin and beta-carotene in the prevention of cardiovascular disease and cancer in 22 071 US physicians with a 12 year follow-up [63] . The Women's Health Study is testing beta-carotene (50 mg on alternate male US physicians aged 40-84 years originally recruited in 1982 [60] . A history of angina pectoris or revascularization days), vitamin E (600IU on alternate days) and aspirin in 40 000 healthy US female nurses [64] . In Britain, the prior to randomization was reported in 333 doctors at entry to the study. Of these 160 were assigned to beta-carotene combined Medical Research Council and British Heart Foundation Heart Protection Study has begun and will test and 173 to placebo. After a mean follow-up of 60.2 months, a significant reduction in CHD events was seen in the the effects of a combined antioxidant preparation as well as Table 4 Possible mechanisms for the protective role of vitamin E Therefore, it is important that such trials also demonstrate against the development of coronary heart disease (CHD).
the safety of long term antioxidant treatment. A significant cardioprotective effect might also have major cost impli-
$ Stabilization of coronary lesions
cations for the routine use of such agents.
-by reducing lipid peroxidation, vitamin E accumulation in the lipid core of an atherosclerotic plaque could reduce macrophage
